Back to search

Article

Benchmarking genome-wide association study causal gene prioritization for drug discovery

2025-09-25

Abstract excerpt

Drug discovery is costly, with billions spent on failed trials. Drugs with genetic support from genome-wide association studies (GWAS) have substantially greater odds of success, but how best to use GWAS to prioritize drug targets remains unclear. We evaluated the performance of GWAS causal gene prioritization methods from the Open Targets consortium by cross-referencing their predictions with drug trial outcomes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98efef94-ab8d-50ef-b5a6-995aaa429ac4
DOI
10.1101/2025.09.23.25336370
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Benchmarking genome-wide association study causal gene prioritization for drug discoveryDOI 10.1101/2025.09.23.25336370
Select a neighboring publication to make it the new centre.